ABVC BioPharma, Inc. ("ABVC" or the "Company") (NASDAQ: ABVC) today addressed recent public discussions surrounding attention-deficit/hyperactivity disorder (ADHD) treatment in the United ...

Powerful psychotropic drugs are often the next step, even though their combined effects in young children haven’t been ...

Is the first pill just the beginning? For many children diagnosed with attention-deficit/hyperactivity disorder, a ...

Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI). Clinical studies have shown that centanafadine significantly reduces core symptoms of ADHD in ...

Tens of thousands of American children who begin with a prescription for Attention Deficit Hyperactivity Disorder (ADHD) ...

A record low 54 major league players were given permission to use medication for ADHD, down from 61 last year and 119 in 2013 ...

For Many Kids, ADHD Pills Kick Off a Drug Cascade” (Page One, Nov. 21) sheds light on the pervasive diagnosing and use of drugs for behavior in otherwise normal children. Because there are no biologic ...

A recent study that included 148,000 people diagnosed with attention deficit hyperactivity disorder (ADHD) found that taking prescribed ADHD medications was linked to lower rates of premature deaths ...

Many of the ADHD medication shortages that have plagued the U.S. for the last two years have now been resolved, the Food and Drug Administration says. Yet some doctors and patients report they are ...

Pfizer and manufacturer Tris Pharma have agreed to hand over $41.5 million to lay to rest a 2023 lawsuit accusing the ...

A record low 54 major league players were given permission to use medication for attention deficit hyperactivity disorder, down from 61 last year and 119 in 2013. The total was revealed Monday in the ...